A detailed history of West Family Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, West Family Investments, Inc. holds 2,066 shares of AMGN stock, worth $544,143. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,066
Previous 1,943 6.33%
Holding current value
$544,143
Previous $607,000 9.56%
% of portfolio
0.23%
Previous 0.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $38,053 - $41,497
123 Added 6.33%
2,066 $665,000
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $21,808 - $26,502
-83 Reduced 4.1%
1,943 $607,000
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $30,382 - $36,675
113 Added 5.91%
2,026 $576,000
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $1,022 - $1,153
-4 Reduced 0.21%
1,913 $550,000
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $86,148 - $106,955
-394 Reduced 17.05%
1,917 $515,000
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $495,177 - $585,538
2,311 New
2,311 $513,000
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $5,038 - $6,402
-22 Reduced 1.07%
2,033 $533,000
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $60,155 - $67,844
268 Added 15.0%
2,055 $463,000
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $102,435 - $113,992
444 Added 33.06%
1,787 $435,000
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $3,727 - $4,123
17 Added 1.28%
1,343 $324,000
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $263,714 - $301,797
1,326 New
1,326 $298,000
Q3 2021

Oct 25, 2021

SELL
$212.27 - $248.7 $345,151 - $404,386
-1,626 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $379,801 - $421,361
1,626 New
1,626 $396,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track West Family Investments, Inc. Portfolio

Follow West Family Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.